CD86 and neoplasm: Additionally, there was a significant increase in the proportion of CD80+ and CD86+ dendritic cells (DCs) within mouse tumor tissues after sgPik3cg-DHP/DGA-NVs treatment, indicating DC activation (Supplementary Fig. 30c).